Literature DB >> 27612988

Marked overlap of four genetic syndromes with dyskeratosis congenita confounds clinical diagnosis.

Amanda J Walne1, Laura Collopy2, Shirleny Cardoso2, Alicia Ellison2, Vincent Plagnol3, Canan Albayrak4, Davut Albayrak4, Sara Sebnem Kilic5, Turkan Patıroglu6, Haluk Akar6, Keith Godfrey7, Tina Carter8, Makia Marafie9, Ajay Vora10, Mikael Sundin11, Thomas Vulliamy2, Hemanth Tummala2, Inderjeet Dokal2.   

Abstract

Dyskeratosis congenita is a highly pleotropic genetic disorder. This heterogeneity can lead to difficulties in making an accurate diagnosis and delays in appropriate management. The aim of this study was to determine the underlying genetic basis in patients presenting with features of dyskeratosis congenita and who were negative for mutations in the classical dyskeratosis congenita genes. By whole exome and targeted sequencing, we identified biallelic variants in genes that are not associated with dyskeratosis congenita in 17 individuals from 12 families. Specifically, these were homozygous variants in USB1 (8 families), homozygous missense variants in GRHL2 (2 families) and identical compound heterozygous variants in LIG4 (2 families). All patients had multiple somatic features of dyskeratosis congenita but not the characteristic short telomeres. Our case series shows that biallelic variants in USB1, LIG4 and GRHL2, the genes mutated in poikiloderma with neutropenia, LIG4/Dubowitz syndrome and the recently recognized ectodermal dysplasia/short stature syndrome, respectively, cause features that overlap with dyskeratosis congenita. Strikingly, these genes also overlap in their biological function with the known dyskeratosis congenita genes that are implicated in telomere maintenance and DNA repair pathways. Collectively, these observations demonstrate the marked overlap of dyskeratosis congenita with four other genetic syndromes, confounding accurate diagnosis and subsequent management. This has important implications for establishing a genetic diagnosis when a new patient presents in the clinic. Patients with clinical features of dyskeratosis congenita need to have genetic analysis of USB1, LIG4 and GRHL2 in addition to the classical dyskeratosis congenita genes and telomere length measurements. Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27612988      PMCID: PMC5046647          DOI: 10.3324/haematol.2016.147769

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  38 in total

Review 1.  Recent discoveries concerning the involvement of transcription factors from the Grainyhead-like family in cancer.

Authors:  Michal Mlacki; Agnieszka Kikulska; Ewa Krzywinska; Magdalena Pawlak; Tomasz Wilanowski
Journal:  Exp Biol Med (Maywood)       Date:  2015-06-10

Review 2.  Ligase IV syndrome.

Authors:  Dimitry A Chistiakov
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 3.  The many facets of H/ACA ribonucleoproteins.

Authors:  U Thomas Meier
Journal:  Chromosoma       Date:  2005-03-16       Impact factor: 4.316

4.  Clericuzio-type Poikiloderma with Neutropenia Syndrome in a Turkish Family: a Three Report of Siblings with Mutation in the C16orf57 gene.

Authors:  Turkan Patiroglu; H Haluk Akar
Journal:  Iran J Allergy Asthma Immunol       Date:  2015-06       Impact factor: 1.464

Review 5.  Ligase IV syndrome.

Authors:  Dimitry A Chistiakov; Natalia V Voronova; Alexander P Chistiakov
Journal:  Eur J Med Genet       Date:  2009-05-23       Impact factor: 2.708

6.  DNA damage responses and oxidative stress in dyskeratosis congenita.

Authors:  Larisa Pereboeva; Erik Westin; Toral Patel; Ian Flaniken; Lawrence Lamb; Aloysius Klingelhutz; Frederick Goldman
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

7.  Hoyeraal-Hreidarsson syndrome caused by a germline mutation in the TEL patch of the telomere protein TPP1.

Authors:  Hande Kocak; Bari J Ballew; Kamlesh Bisht; Rebecca Eggebeen; Belynda D Hicks; Shalabh Suman; Adri O'Neil; Neelam Giri; Ivan Maillard; Blanche P Alter; Catherine E Keegan; Jayakrishnan Nandakumar; Sharon A Savage
Journal:  Genes Dev       Date:  2014-09-18       Impact factor: 12.890

8.  Aberrant 3' oligoadenylation of spliceosomal U6 small nuclear RNA in poikiloderma with neutropenia.

Authors:  Christine Hilcenko; Paul J Simpson; Andrew J Finch; Frank R Bowler; Mark J Churcher; Li Jin; Len C Packman; Adam Shlien; Peter Campbell; Michael Kirwan; Inderjeet Dokal; Alan J Warren
Journal:  Blood       Date:  2012-11-27       Impact factor: 22.113

9.  Telomere length measurement by a novel monochrome multiplex quantitative PCR method.

Authors:  Richard M Cawthon
Journal:  Nucleic Acids Res       Date:  2009-01-07       Impact factor: 16.971

10.  Dubowitz syndrome is a complex comprised of multiple, genetically distinct and phenotypically overlapping disorders.

Authors:  Douglas R Stewart; Alexander Pemov; Jennifer J Johnston; Julie C Sapp; Meredith Yeager; Ji He; Joseph F Boland; Laurie Burdett; Christina Brown; Richard A Gatti; Blanche P Alter; Leslie G Biesecker; Sharon A Savage
Journal:  PLoS One       Date:  2014-06-03       Impact factor: 3.240

View more
  15 in total

1.  Myelodysplasia and liver disease extend the spectrum of RTEL1 related telomeropathies.

Authors:  Shirleny R Cardoso; Alicia C M Ellison; Amanda J Walne; David Cassiman; Manoj Raghavan; Bhuvan Kishore; Philip Ancliff; Carmen Rodríguez-Vigil; Bieke Dobbels; Ana Rio-Machin; Ahad F H Al Seraihi; Nikolas Pontikos; Hemanth Tummala; Tom Vulliamy; Inderjeet Dokal
Journal:  Haematologica       Date:  2017-05-11       Impact factor: 9.941

Review 2.  Functional roles of Grainyhead-like transcription factors in renal development and disease.

Authors:  Felix J Boivin; Kai M Schmidt-Ott
Journal:  Pediatr Nephrol       Date:  2018-12-15       Impact factor: 3.714

3.  GRHL2 Is Required for Collecting Duct Epithelial Barrier Function and Renal Osmoregulation.

Authors:  Christian Hinze; Janett Ruffert; Katharina Walentin; Nina Himmerkus; Elham Nikpey; Olav Tenstad; Helge Wiig; Kerim Mutig; Zeliha Yesim Yurtdas; Janet D Klein; Jeff M Sands; Federica Branchi; Michael Schumann; Sebastian Bachmann; Markus Bleich; Kai M Schmidt-Ott
Journal:  J Am Soc Nephrol       Date:  2017-12-13       Impact factor: 10.121

Review 4.  New monogenic disorders identify more pathways to neutropenia: from the clinic to next-generation sequencing.

Authors:  Seth J Corey; Usua Oyarbide
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

5.  Poikiloderma with Neutropenia in Morocco: a Report of Four Cases.

Authors:  Ayoub Aglaguel; Houria Abdelghaffar; Fatima Ailal; Norddine Habti; Sebastian Hesse; Naschla Kohistani; Christoph Klein; Ahmed Aziz Bousfiha
Journal:  J Clin Immunol       Date:  2017-03-28       Impact factor: 8.317

Review 6.  Genetics of human telomere biology disorders.

Authors:  Patrick Revy; Caroline Kannengiesser; Alison A Bertuch
Journal:  Nat Rev Genet       Date:  2022-09-23       Impact factor: 59.581

7.  Insights into Mutation Effect in Three Poikiloderma with Neutropenia Patients by Transcript Analysis and Disease Evolution of Reported Patients with the Same Pathogenic Variants.

Authors:  Elisa A Colombo; Nursel H Elcioglu; Claudio Graziano; Pamela Farinelli; Elisabetta Di Fede; Iria Neri; Elena Facchini; Mariangela Greco; Cristina Gervasini; Lidia Larizza
Journal:  J Clin Immunol       Date:  2018-05-16       Impact factor: 8.317

8.  The Role of Genetic Testing in Hereditary Poikiloderma: A Case Report.

Authors:  Sarah El-Heis; Keith M Godfrey
Journal:  Glob Pediatr Health       Date:  2017-06-28

9.  Genome instability is a consequence of transcription deficiency in patients with bone marrow failure harboring biallelic ERCC6L2 variants.

Authors:  Hemanth Tummala; Arran D Dokal; Amanda Walne; Alicia Ellison; Shirleny Cardoso; Saranha Amirthasigamanipillai; Michael Kirwan; Isobel Browne; Jasmin K Sidhu; Vinothini Rajeeve; Ana Rio-Machin; Ahad Al Seraihi; Andrew S Duncombe; Matthew Jenner; Owen P Smith; Helen Enright; Alice Norton; Tekin Aksu; Namık Yaşar Özbek; Nikolas Pontikos; Pedro Cutillas; Inderjeet Dokal; Tom Vulliamy
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-09       Impact factor: 11.205

Review 10.  When Should We Think of Myelodysplasia or Bone Marrow Failure in a Thrombocytopenic Patient? A Practical Approach to Diagnosis.

Authors:  Nicolas Bonadies; Alicia Rovó; Naomi Porret; Ulrike Bacher
Journal:  J Clin Med       Date:  2021-03-02       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.